{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T05:54:57Z","timestamp":1719986097830},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1991,3,1]],"date-time":"1991-03-01T00:00:00Z","timestamp":667785600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1991,3]]},"DOI":"10.1007\/bf02244293","type":"journal-article","created":{"date-parts":[[2005,11,14]],"date-time":"2005-11-14T16:59:05Z","timestamp":1131987545000},"page":"380-383","source":"Crossref","is-referenced-by-count":17,"title":["Differential effects of selective\u00b5-,\u03ba- and\u03b4-opioid antagonists on electroshock seizure threshold in mice"],"prefix":"10.1007","volume":"103","author":[{"given":"Helen C.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. J.","family":"Nutt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02244293_CR1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0028-3908(84)90200-4","volume":"23","author":"EF Berman","year":"1984","unstructured":"Berman EF, Adler MW (1984) The anticonvulsant effect of opioids and opioid peptides against maximal electroshock seizures in rats. Neuropharmacology 23:367\u2013371","journal-title":"Neuropharmacology"},{"key":"BF02244293_CR2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0014-2999(87)90397-9","volume":"144","author":"PJ Birch","year":"1987","unstructured":"Birch PJ, Hayes AG, Sheehan MJ, Tyers MB (1987) Norbinaltorphimine: antagonist profile at\u03ba opioid receptors. Eur J Pharmacol 144:405\u2013408","journal-title":"Eur J Pharmacol"},{"key":"BF02244293_CR3","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0028-3908(82)90113-7","volume":"21","author":"LD Calder","year":"1982","unstructured":"Calder LD, Snyder EW, Dustman RE (1982) Naloxone-induced epileptogenesis has brainsite specificity in rats. Neuropharmacology 21:1001\u20131004","journal-title":"Neuropharmacology"},{"key":"BF02244293_CR4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1476-5381.1985.tb10562.x","volume":"85","author":"AD Corbett","year":"1985","unstructured":"Corbett AD, Kosterlitz HE, McKnight AT, Paterson SJ, Robson LE (1985) Pre-incubation of guinea-pig myenteric plexus with \u03b2-funaltrexamine: discrepancy between binding assays and bioassays. Br J Pharmacol 85:665\u2013673","journal-title":"Br J Pharmacol"},{"key":"BF02244293_CR5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0014-2999(87)90673-X","volume":"142","author":"A Czlonkowski","year":"1987","unstructured":"Czlonkowski A, Millan MJ, Herz A (1987) The selective\u03ba-opioid agonist, U-50,488H, produces antinociception in the rat via a supraspinal action. Eur J Pharmacol 142:183\u2013184","journal-title":"Eur J Pharmacol"},{"key":"BF02244293_CR6","volume-title":"Probit analysis","author":"DJ Finney","year":"1971","unstructured":"Finney DJ (1971) Probit analysis. Cambridge University Press, Cambridge"},{"key":"BF02244293_CR7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-0773.1988.tb01863.x","volume":"62","author":"H-H Frey","year":"1988","unstructured":"Frey H-H (1988) Effect of\u00b5- and\u03ba-opioid agonists on the electro-convulsive seizure threshold in mice and antagonism by naloxone and MR 2266. Pharmacol Toxicol 62:150\u2013154","journal-title":"Pharmacol Toxicol"},{"key":"BF02244293_CR8","first-page":"538","volume":"192","author":"PE Gilbert","year":"1975","unstructured":"Gilbert PE, Martin WR (1975) Antagonism of the convulsant effects of heroin,d-propoxyphene, meperidine, normeperidine and thebaine by naloxone in mice. J Pharmacol Exp Ther 192:538\u2013541","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02244293_CR9","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/0028-3908(89)90022-1","volume":"28","author":"HC Jackson","year":"1989","unstructured":"Jackson HC, Ripley TL, Nutt DJ (1989) Exploring\u03b4-receptor function using the selective opioid antagonist naltrindole. Neuropharmacology 28:1427\u20131430","journal-title":"Neuropharmacology"},{"key":"BF02244293_CR10","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0024-3205(87)90585-6","volume":"40","author":"PS Portoghese","year":"1987","unstructured":"Portoghese PS, Lipkowski AW, Takemori AE (1987) Binaltorphimine and nor-binaltorphimine, potent and selective\u03ba-opioid receptor antagonists. Life Sci 40:1287\u20131292","journal-title":"Life Sci"},{"key":"BF02244293_CR11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0014-2999(88)90502-X","volume":"146","author":"PS Portoghese","year":"1988","unstructured":"Portoghese PS, Sultana M, Takemori AE (1988) Naltrindole, a highly selective and potent non-peptide\u03b4 opioid receptor antagonist. Eur J Pharmacol 146:185\u2013186","journal-title":"Eur J Pharmacol"},{"key":"BF02244293_CR12","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0091-3057(84)90197-7","volume":"20","author":"S Puglisi-Allegra","year":"1984","unstructured":"Puglisi-Allegra S, Castellano C, Csanyl V, Doka A, Oliverio A (1984) Opioid antagonism of electroshock-induced seizures. Pharmacol Biochem Behav 20:767\u2013769","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02244293_CR13","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/0024-3205(79)90403-X","volume":"25","author":"J Sawynok","year":"1979","unstructured":"Sawynok J, Pinsky C, LaBella FS (1979) Minireview on the specificity of naloxone as an opiate antagonist. Life Sci 25:1621\u20131632","journal-title":"Life Sci"},{"key":"BF02244293_CR14","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1021\/jm00122a021","volume":"32","author":"H Schmidhammer","year":"1989","unstructured":"Schmidhammer H, Burkard WP, Eggstein-Aeppli L, Smith CFC (1989) Synthesis and biological evaluation of 14-alkoxymorphinans. 2. (-)-N-(cyclopropylmethyl)-4,14-dimethoxymorphinan-6-one, a selective\u00b5 opioid receptor antagonist. J Med Chem 32:418\u2013421","journal-title":"J Med Chem"},{"key":"BF02244293_CR15","first-page":"1","volume":"242","author":"JE Shook","year":"1987","unstructured":"Shook JE, Pelton JL, Lemcke PN, Porreca F, Hruby VJ, Burks TF (1987) Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functions. J Pharmacol Exp Ther 242:1\u20137","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02244293_CR16","first-page":"433","volume-title":"Experimental models of epilepsy \u2014 a manual for the laboratory worker","author":"EA Swinyard","year":"1972","unstructured":"Swinyard EA (1972) Electrically induced convulsions. In: Purpura DP, Penry JN, Tower DB, Woodbury DM, Walter RD (eds) Experimental models of epilepsy \u2014 a manual for the laboratory worker. Raven Press, New York, pp 433\u2013458"},{"key":"BF02244293_CR17","first-page":"255","volume":"246","author":"AE Takemori","year":"1988","unstructured":"Takemori AE, Ho BY, Naeseth JS, Portoghese PS (1988a) Norbinaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J Pharmacol Exp Ther 246:255\u2013258","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02244293_CR18","first-page":"971","volume":"247","author":"AE Takemori","year":"1988","unstructured":"Takemori AE, Schwartz MM, Portoghese PS (1988b) Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats. J Pharmacol Exp Ther 247:971\u2013974","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02244293_CR19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0006-8993(88)90355-1","volume":"456","author":"FC Tortella","year":"1988","unstructured":"Tortella FC, Long JB (1988) Characterization of opioid peptide-like anticonvulsant activity in rat cerebrospinal fluid. Brain Res 456:139\u2013146","journal-title":"Brain Res"},{"key":"BF02244293_CR20","first-page":"49","volume":"237","author":"FC Tortella","year":"1986","unstructured":"Tortella FC, Robles L, Holaday JW (1986) U50,488, a highly selective kappa opioid: anticonvulsant profile in rats. J Pharmacol Exp Ther 237:49\u201353","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02244293_CR21","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/0196-9781(88)90104-0","volume":"9","author":"FC Tortella","year":"1988","unstructured":"Tortella FC, Echevarria E, Robles L, Mosberg HI, Holaday JW (1988) Anticonvulsant effects of mu (DAGO) and delta (DPDPE) enkephalins in rats. Peptides 9:1177\u20131181","journal-title":"Peptides"},{"key":"BF02244293_CR22","first-page":"387","volume":"75","author":"FC Tortella","year":"1989","unstructured":"Tortella FC, Echevarria E, Holaday JW, Kazmierski W, Hruby VJ, Burks TF, Shook JE (1989a) Opioid antagonist properties of CTP, a somatostatin analog: in vivo selectivity for\u00b5-directed ligands. Adv Biosci 75:387\u2013390","journal-title":"Adv Biosci"},{"key":"BF02244293_CR23","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0024-3205(89)90470-0","volume":"44","author":"FC Tortella","year":"1989","unstructured":"Tortella FC, Echevarria E, Lipkowski AW, Takemori AE, Portoghese PS, Holaday JW (1989b) Selective kappa antagonist properties of nor-binaltorphimine in the rat MES seizure model. Life Sci 44:661\u2013665","journal-title":"Life Sci"},{"key":"BF02244293_CR24","doi-asserted-by":"crossref","first-page":"PL-1","DOI":"10.1016\/0024-3205(90)90501-H","volume":"46","author":"FC Tortella","year":"1990","unstructured":"Tortella FC, Robles L, Echevarria E, Hunter JC, Hughes J (1990) PD117302, a selective non-peptide opioid kappa agonist, protects against NMDA and maximal electroshock convulsions in rats. Life Sci 46:PL-1\u2013PL-7","journal-title":"Life Sci"},{"key":"BF02244293_CR25","first-page":"109","volume":"75","author":"JR Traynor","year":"1989","unstructured":"Traynor JR, Hayes AG, Lawrence AJ (1989) Binding profile of the potent selective\u03ba antagonist norbinaltorphimine. Adv Biosci 75:109\u2013112","journal-title":"Adv Biosci"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02244293.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02244293\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02244293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T19:32:00Z","timestamp":1557862320000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02244293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1991,3]]}},"alternative-id":["BF02244293"],"URL":"https:\/\/doi.org\/10.1007\/bf02244293","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,3]]}}}